Semaglutide: How can it support diabetes and weight loss?
Published Jun 20, 2025 • By Somya Pokharna
Have you heard about Ozempic, Wegovy, or Rybelsus and wondered what they actually do, or if they're right for you? These widely discussed medications are all forms of a drug called semaglutide, originally developed to help manage type 2 diabetes but now also approved for weight loss.
So, how do semaglutides contribute to blood sugar control and weight loss? What are the different types available, and what to consider in terms of safety and side effects?
Whether you're just hearing about semaglutides or considering a prescription, read on to find out if they could support your health journey.

What are semaglutides, and how do they work?
Semaglutides belong to a class of medications known as GLP-1 receptor agonists. GLP-1 stands for “glucagon-like peptide-1,” a hormone your body naturally produces in response to eating. This hormone helps regulate blood sugar, insulin levels, and appetite.
Semaglutide mimics the action of GLP-1, producing several helpful effects. It increases insulin secretion when blood sugar is high, helping lower glucose levels, while also suppressing glucagon, a hormone that raises blood sugar. It slows how quickly food moves through your digestive system, which helps you feel full longer, and it acts on the brain to reduce hunger and food cravings. These combined actions make semaglutide effective for managing type 2 diabetes and, in higher doses, promoting significant weight loss.
Who can benefit from semaglutide medications?
Semaglutide is prescribed for adults with type 2 diabetes and for those living with obesity or overweight alongside other health conditions. If you’ve been unable to lose weight through lifestyle changes alone or if your blood sugar remains high despite diet and exercise, semaglutide might be appropriate.
The drug is FDA-approved under different brand names depending on the indication. Ozempic is used to treat type 2 diabetes and also reduces the risk of cardiovascular events like heart attack or stroke. Rybelsus offers the same benefits in an oral tablet. Wegovy is a higher-dose injectable approved for long-term weight management. It’s intended for people with a body mass index (BMI) of 30 or more, or 27 or more if they also have a related health issue such as high blood pressure, or cholesterol. Healthcare providers consider your medical history, weight, and overall health when determining if semaglutide is a good fit.
What are the different types of semaglutides?
Although all semaglutide medications use the same active ingredient, they differ in form, dosing, and intended use. Understanding these differences can help you and your doctor choose the best option.
- Ozempic is a once-weekly injection approved for people with type 2 diabetes. It helps control blood sugar and is also known for its heart-protective benefits in those with cardiovascular disease.
- Rybelsus contains semaglutide in tablet form and is taken once daily. It offers a needle-free alternative for managing type 2 diabetes, though it must be taken on an empty stomach and can be affected by food or drink.
- Wegovy, also a weekly injection, is specifically formulated and approved for weight loss. It uses higher doses of semaglutide than Ozempic and has shown strong results in helping individuals lose and maintain weight.
Each version of semaglutide is tailored to a particular need, but they all work through the same basic mechanism, by enhancing insulin response and reducing appetite.
Are semaglutides safe? What are the side effects?
Semaglutides are generally well-tolerated and considered safe, but like any medication, they carry risks. The most commonly reported side effects include:
- Nausea
- Vomiting
- Diarrhea or constipation
- Stomach pain
- Headache
- Fatigue
These symptoms are usually mild and tend to improve as your body adjusts to the medication. Starting at a low dose and increasing gradually helps reduce these effects.
More serious but less common risks include:
- Pancreatitis (inflammation of the pancreas)
- Gallbladder disease
- Kidney injury, especially if you become dehydrated
- Diabetic retinopathy worsening, particularly in people using insulin
- Thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), seen in animal studies
Because of these risks, semaglutide isn’t recommended for persons with a personal or family history of MTC or multiple endocrine neoplasia syndrome type 2 (MEN 2). Always discuss your full medical history with your doctor before starting treatment.
Large clinical trials like SUSTAIN, PIONEER, and STEP have consistently shown semaglutide’s safety and effectiveness, both for diabetes management and long-term weight loss.
What should I know before starting semaglutide?
Before beginning semaglutide treatment, it's important to have a thorough discussion with your healthcare provider. You’ll need to review your full medical history, including any prior issues with thyroid disease, kidney function, pancreas health, or diabetic eye conditions. If you're pregnant, planning to become pregnant, or breastfeeding, semaglutide is not recommended.
The way semaglutide is taken varies depending on the version:
- Ozempic and Wegovy are injected once weekly, usually into the stomach or thigh.
- Rybelsus is taken by mouth once daily, but must be swallowed with plain water on an empty stomach, followed by no food, drink, or other medications for at least 30 minutes.
You'll typically start with a low dose and increase gradually under medical supervision. Regular check-ups will help monitor for side effects and track progress in blood sugar levels, weight loss, and overall health. Because these medications can be expensive, ask your provider about savings programs or manufacturer coupons, which may reduce out-of-pocket costs.
Most importantly, remember that semaglutide is meant to work alongside a healthy lifestyle, not in place of it. Diet, exercise, and behavioral changes remain vital components of long-term success.
Did you find this article helpful?
Give it a “Like” and share your thoughts and questions with the community in the comments below!
Take care!
Sources:
Adkison, J. (2022). Comparing Ozempic, Wegovy and Other GLP-1 Drugs. GoodRx.
Goldenberg, R. M., & Steen, O. (2019). Semaglutide: review and place in therapy for adults with type 2 diabetes. Canadian Journal of Diabetes, 43(2), 136-145.
Kommu S, Whitfield P. (2024). Semaglutide. StatPearls Publishing.
Mayo Clinic Staff. (2025). Pros and cons of weight-loss drugs. Mayo Clinic.
Smits, M. M., & Van Raalte, D. H. (2021). Safety of semaglutide. Frontiers in endocrinology, 12, 645563.
Comments
You will also like

Diabetes: Discrimination, Professional Life, Plan Ahead... What do patients say?
Nov 9, 2018 • 9 comments